The company is a Korea-based company principally engaged in the research, development and supply of biopharmaceuticals. The Company is principally engaged in the research, development and supply of biopharmaceuticals such as cell therapy products and diagnostic products. In addition, the Company is engaged in the provision of contract development and manufacturing organization (CDMO) services. The company was incorporated on December 23, 2015 and its shares are listed on KONEX Exchange on July 31, 2023.
Headquarters
M-1903, 32, Songdogwahak-Ro, Yeonsu-Gu
Incheon; Incheon;
Contact Details: Purchase the Epi Biotech Co. Ltd. report to view the information.
Website: http://epibiotech.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service